Proscia is a company that provides an enterprise pathology platform for digital pathology data and AI applications, bridging the gap between anatomic pathology laboratories and life sciences organizations.

David West

Coleman Stavish

Nathan Buchbinder

Proscia

American Pathology Partners no longer provides laboratory or pathology services after selling its operations in multiple states.

American Pathology Partners

SIEHT is a healthcare provider specializing in eye care services, including cataract surgery, LASIK vision correction, glaucoma treatment, and general eye exams.

SIEHT

Proscia is fighting cancer with intelligent software that changes the way the world practices pathology. Join us.

A-Level Capital

Robin Hood Ventures

SoGal Ventures

Emerald Development Managers

Flybridge

Razor's Edge Ventures

Fusion Fund

Hitachi Ventures

Scale Venture Partners

Triangle Peak Partners

Alpha Intelligence Capital

Highline Capital Management

ROBO Global

Metric
Company Name	Proscia	American Pathology Partners	SIEHT
Symbol
MSH ID	COM:PROSCIA	COM:AP2	COM:SIEHT
Market	PRIVATE	PRIVATE	PRIVATE
Sector	9	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Health Services	Optometry
Country	US	US	US
Stage
Employee Count	94	251
Website	proscia.com	ap2.com	sieht.com
LinkedIn	proscia
Founders

Metric
Market Cap	55M
Enterprise Value
Monthly Web Traffic		419
Web Traffic Growth		-0.85
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:PROSCIA

Proscia

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue